Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 31;228(5):646-656.
doi: 10.1093/infdis/jiad261.

Prevotella and Gardnerella Are Associated With Treatment Failure Following First-line Antibiotics for Bacterial Vaginosis

Affiliations

Prevotella and Gardnerella Are Associated With Treatment Failure Following First-line Antibiotics for Bacterial Vaginosis

Erica L Plummer et al. J Infect Dis. .

Abstract

Background: Bacterial vaginosis (BV) is a common vaginal dysbiosis that often recurs following first-line antibiotics. We investigated if vaginal microbiota composition was associated with BV recurrence.

Methods: We analyzed samples and data from 121 women who participated in 3 published trials evaluating novel interventions for improving BV cure, including concurrent antibiotic treatment of regular sexual partners (RSPs). Women diagnosed with BV received first-line antibiotics and self-collected vaginal swabs pretreatment and the day after finishing antibiotics (immediately posttreatment). 16S rRNA gene sequencing was performed on vaginal samples. Logistic regression explored associations between BV recurrence and features of the vaginal microbiota pre- and posttreatment.

Results: Sixteen women (13% [95% confidence interval {CI}, 8%-21%]) experienced BV recurrence within 1 month of treatment. Women with an untreated RSP were more likely to experience recurrence than women with no RSP (P = .008) or an RSP who received treatment (P = .011). A higher abundance of Prevotella pretreatment (adjusted odds ratio [AOR], 1.35 [95% CI, 1.05-1.91]) and Gardnerella immediately posttreatment (AOR, 1.23 [95% CI, 1.03-1.49]) were associated with increased odds of BV recurrence.

Conclusions: Having specific Prevotella spp prior to recommended treatment and persistence of Gardnerella immediately posttreatment may contribute to the high rates of BV recurrence. Interventions that target these taxa are likely required to achieve sustained BV cure.

Keywords: Gardnerella; Prevotella; bacterial vaginosis; regular sexual partner; vaginal microbiota.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Figure 1.
Figure 1.
Diversity metrics of the vaginal microbiota of women who experienced bacterial vaginosis recurrence and those that remained cured at 1 month postenrollment. Nonmetric multidimensional scaling plots of the overall composition of the vaginal microbiota pretreatment (A) and immediately posttreatment (B). Box plots showing the bacterial diversity (measured using the Shannon diversity index) of the vaginal microbiota of cure and recurrence cases pretreatment and immediately posttreatment (C). Box plots displaying differences in the compositional change of the vaginal microbiota following treatment (measured using Bray–Curtis distances calculated between paired pretreatment and immediate posttreatment samples) between cure and recurrence cases (D). Abbreviations: ANOSIM, analysis of similarity; NMDS, nonmetric multidimensional scaling.

Similar articles

Cited by

References

    1. Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis 2019; 46:304–11. - PubMed
    1. McKinnon LR, Achilles SL, Bradshaw CS, et al. . The evolving facets of bacterial vaginosis: implications for HIV transmission. AIDS Res Hum Retrovir 2019; 35:219–28. - PMC - PubMed
    1. Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev 2009; 3:CD006055. - PubMed
    1. Bradshaw CS, Morton AN, Hocking J, et al. . High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193:1478–86. - PubMed
    1. Bilardi JE, Walker S, Temple-Smith M, et al. . The burden of bacterial vaginosis: women's experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One 2013; 8:e74378. - PMC - PubMed

Publication types